Faculty

Walter Van Dyck

Prof Walter Van Dyck 
Associate Professor of Technology & Innovation Management at Vlerick Business School

Walter studies idea emergence, showing how inventions come about and transform into innovative business models in life science- and technology-based ecosystems. Over the last 8 years, using ‘Entrepreneurial Boot Camp’ active learning formats, Walter has coached the emergence of more than 100 innovative ideas in global and multinational companies in the life sciences, smart systems and clean technology, and their combinations.
Katia Tieleman

Prof Katia Tieleman 
Professor of Negotiation & Conflict Management at Vlerick Business School

Katia Tieleman is Professor in Negotiation and Conflict Management at Vlerick Business School and a leading authority in the field of negotiations. She is affiliated with the Harvard Program on Negotiation at Harvard Law School. For her high impact interventions, Katia draws from her sophisticated academic background as well as from her rich experience as a practitioner. Katia is the author of the Negotiation Intelligence® (NQ®) approach, providing the concept and tools to boost individual and organisational negotiation and cooperation capabilities. As such she helps participants to develop their personal beliefs and skills, and supports them to broker agreements, to maximise their influence, to develop common ground within and across organisations and to use diversity and complexity to their advantage.
Kurt Verweire

Prof Leonardo Meeus
Professor of Strategy and Corporate Affairs at Vlerick Business School

Leonardo is passionate about the relations between companies, stakeholders and government. He helps companies to gain competitive advantage by taking a broader perspective on strategy. He puts strategy into corporate affairs, and corporate affairs into strategy. He directs the Vlerick Energy Centre, one of the strategic focus areas in the School.
 

Walter Sermeus
Professor in Healthcare Management at Leuven Institute for Healthcare Policy at KU Leuven

Walter is Program Director of the Master of Science in Healthcare Management and Policy, KU Leuven. He teaches healthcare management and health services research methods in different masters. He is head of the KU Leuven WHO Collaborating Centre on Human Resources for Health Research and Policy.

 

Dirk De Ridder
Professor of Medicine/Urology at KU Leuven

Dirk is chairman of the department urology and department head of the Leuven Institute for health care policy. He is strategic coordinator of the Flemish hospital network and is a member of the board of UZ Leuven. He is co-director of the Health Sciences & Business Institute, a collaboration between the LIGB and Vlerick Business School.

Frank Rademakers
Professor of Medicine/Cardiology at KU Leuven

Frank is Chief Medical Technology Officer at the University Hospitals Leuven, responsible for the diagnostic departments (Imaging and Laboratories), Pharmacy, IT and Innovation. He teaches Innovation and Change Management and coordinates the contacts with industrial partners with respect to new technologies and innovation. He is Board Member of several hospitals in Flanders as well as spin-off companies of KU Leuven.

Drive real change in your organisation

A learning experience with real impact on your operations? A management programme tailored to the specific needs of your business? Contact us and discover how we can design and deliver customised programmes for your team that add genuine value to your organisation.

Need help?

Contact our Programme Advisor
Programme Advisor
Tel + 32 9 210 98 84
[email protected]
Find the programme most relevant for you!

Download our programme calendar

Meet Us

Info Sessions & Open Days
08 Dec
Meet our programme advisor online
Category: General Info Sessions

Our approach to learning

It’s all about you and your company’s challenges at Vlerick Business School. Discover our unique approach to learning!

Vlerick expertise in Healthcare Management

  1. How to determine the hospital treatment costs for breast cancer patients?

    Healthcare costs are on the rise globally. And factors such as the increase in aging population, advancement in medical technology, and the current reimbursement system contribute to this rise. In addition, we see a lack of cost transparency and understanding centred around costs. A new study by doctoral researcher Erin Roman, Professor Brecht Cardoen and Professor Filip Roodhooft analyses the variability in treatment costs for breast cancer, using several patient and disease related factors, to better understand cost drivers.
  2. COVID-19 vaccines: What if we don’t have enough of them?

    Vaccines usually have complex manufacturing processes and long production lead times. It is likely that we will face acute shortages in the initial period after the vaccine is produced. We will then have to rely on good targeting and rationing strategies for the quantity of vaccines available. Traditional inventory management systems using backlog or underage costs are generally improper in the human life context. Research by Professor Behzad Samii weighs out other inventory allocation mechanisms.
All articles